Owning The Disease II: Adapting Strategy Into Successful Business Tactics

Article preview from IN VIVO - April, 2013

 Owning the Disease represents a powerful new business model for medical technology companies as they seek to adapt to health care reform and a changing environment. Organizations that successfully own a disease align their incentives with those of other stakeholders in the market by developing the capabilities to deliver compelling new value propositions.

Owning The Disease II: Adapting Strategy Into Successful Business Tactics

Article preview from IN VIVO - April, 2013

Owning the disease represents a powerful new business model for medical technology companies as they seek to adapt to health care reform and a changing environment. Organizations that successfully own a disease align their incentives with those of other stakeholders in the market by developing the capabilities to deliver compelling new value propositions.

Financial constraints, policy reforms, demonstration of value via outcomes data and technological advances over the past decade have altered the economics and operational dynamics of health care. Enabled by a confluence of disruptive technologies, novel collaborations and consolidation of related industries, participants in the historically linear health care value chain are creating new markets and business models that deliver greater health benefit more efficiently

Faced with the need to change their historical business models, some of the most advanced medical technology companies are adapting by migrating from an episodic or intervention-focused business model to a convergent care model that enables them to provide solutions along the continuum of care. The integrated solutions inherent in this approach to “owning the disease” combine drug, device, diagnostic, and consumer-centric solutions to establish creative platforms in which a company can dominate the diagnosis and treatment of a disease or condition.

Continued...

Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed.

Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512